238 related articles for article (PubMed ID: 33727749)
21. Association study between common variations in some candidate genes and prostate adenocarcinoma predisposition through multi-stage approach in Iranian population.
Beikzadeh B; Angaji SA; Abolhasani M
BMC Med Genet; 2020 Apr; 21(1):81. PubMed ID: 32295536
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.
Hoffmann TJ; Passarelli MN; Graff RE; Emami NC; Sakoda LC; Jorgenson E; Habel LA; Shan J; Ranatunga DK; Quesenberry CP; Chao CR; Ghai NR; Aaronson D; Presti J; Nordström T; Wang Z; Berndt SI; Chanock SJ; Mosley JD; Klein RJ; Middha M; Lilja H; Melander O; Kvale MN; Kwok PY; Schaefer C; Risch N; Van Den Eeden SK; Witte JS
Nat Commun; 2017 Jan; 8():14248. PubMed ID: 28139693
[TBL] [Abstract][Full Text] [Related]
23. Genetic predisposition to prostate cancer.
Benafif S; Eeles R
Br Med Bull; 2016 Dec; 120(1):75-89. PubMed ID: 27941040
[TBL] [Abstract][Full Text] [Related]
24. Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels.
Parikh H; Wang Z; Pettigrew KA; Jia J; Daugherty S; Yeager M; Jacobs KB; Hutchinson A; Burdett L; Cullen M; Qi L; Boland J; Collins I; Albert TJ; Vatten LJ; Hveem K; Njølstad I; Cancel-Tassin G; Cussenot O; Valeri A; Virtamo J; Thun MJ; Feigelson HS; Diver WR; Chatterjee N; Thomas G; Albanes D; Chanock SJ; Hunter DJ; Hoover R; Hayes RB; Berndt SI; Sampson J; Amundadottir L
Hum Genet; 2011 Jun; 129(6):675-85. PubMed ID: 21318478
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms in prostate-specific antigen (PSA) gene, risk of prostate cancer, and serum PSA levels in Japanese population.
Wang LZ; Sato K; Tsuchiya N; Yu JG; Ohyama C; Satoh S; Habuchi T; Ogawa O; Kato T
Cancer Lett; 2003 Dec; 202(1):53-9. PubMed ID: 14643026
[TBL] [Abstract][Full Text] [Related]
26. Evaluating genetic risk for prostate cancer among Japanese and Latinos.
Cheng I; Chen GK; Nakagawa H; He J; Wan P; Laurie CC; Shen J; Sheng X; Pooler LC; Crenshaw AT; Mirel DB; Takahashi A; Kubo M; Nakamura Y; Al Olama AA; Benlloch S; Donovan JL; Guy M; Hamdy FC; Kote-Jarai Z; Neal DE; Wilkens LR; Monroe KR; Stram DO; Muir K; Eeles RA; Easton DF; Kolonel LN; Henderson BE; Le Marchand L; Haiman CA
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2048-58. PubMed ID: 22923026
[TBL] [Abstract][Full Text] [Related]
27. Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels.
Cramer SD; Chang BL; Rao A; Hawkins GA; Zheng SL; Wade WN; Cooke RT; Thomas LN; Bleecker ER; Catalona WJ; Sterling DA; Meyers DA; Ohar J; Xu J
J Natl Cancer Inst; 2003 Jul; 95(14):1044-53. PubMed ID: 12865450
[TBL] [Abstract][Full Text] [Related]
28. A G/A polymorphism in the androgen response element 1 of prostate-specific antigen gene correlates with the response to androgen deprivation therapy in Japanese population.
Shibahara T; Onishi T; Franco OE; Arima K; Nishikawa K; Yanagawa M; Hioki T; Watanabe M; Hirokawa Y; Shiraishi T; Sugimura Y
Anticancer Res; 2006; 26(5A):3365-71. PubMed ID: 17094454
[TBL] [Abstract][Full Text] [Related]
29. Genetic variation in KLK2 and KLK3 is associated with concentrations of hK2 and PSA in serum and seminal plasma in young men.
Sävblom C; Halldén C; Cronin AM; Säll T; Savage C; Vertosick EA; Klein RJ; Giwercman A; Lilja H
Clin Chem; 2014 Mar; 60(3):490-9. PubMed ID: 24270797
[TBL] [Abstract][Full Text] [Related]
30. Replication study of 34 common SNPs associated with prostate cancer in the Romanian population.
Jinga V; Csiki IE; Manolescu A; Iordache P; Mates IN; Radavoi D; Rascu S; Badescu D; Badea P; Mates D
J Cell Mol Med; 2016 Apr; 20(4):594-600. PubMed ID: 26773531
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms in the prostate-specific antigen gene promoter do not predict serum prostate-specific antigen levels in African-American men.
Beebe-Dimmer JL; Lange LA; Cain JE; Lewis RC; Ray AM; Sarma AV; Lange EM; Cooney KA
Prostate Cancer Prostatic Dis; 2006; 9(1):50-5. PubMed ID: 16247489
[TBL] [Abstract][Full Text] [Related]
32. Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese.
Akamatsu S; Takata R; Haiman CA; Takahashi A; Inoue T; Kubo M; Furihata M; Kamatani N; Inazawa J; Chen GK; Le Marchand L; Kolonel LN; Katoh T; Yamano Y; Yamakado M; Takahashi H; Yamada H; Egawa S; Fujioka T; Henderson BE; Habuchi T; Ogawa O; Nakamura Y; Nakagawa H
Nat Genet; 2012 Feb; 44(4):426-9, S1. PubMed ID: 22366784
[TBL] [Abstract][Full Text] [Related]
33. Search for genetic factor association with cancer-free prostate-specific antigen level elevation on the basis of a genome-wide association study in the Korean population.
Choe EK; Lee Y; Cho JY; Choi SH; Park B; Lee JE; Cho EY
Eur J Cancer Prev; 2018 Sep; 27(5):453-460. PubMed ID: 28471803
[TBL] [Abstract][Full Text] [Related]
34. Genome scan study of prostate cancer in Arabs: identification of three genomic regions with multiple prostate cancer susceptibility loci in Tunisians.
Shan J; Al-Rumaihi K; Rabah D; Al-Bozom I; Kizhakayil D; Farhat K; Al-Said S; Kfoury H; Dsouza SP; Rowe J; Khalak HG; Jafri S; Aigha II; Chouchane L
J Transl Med; 2013 May; 11():121. PubMed ID: 23668334
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms influencing prostate-specific antigen concentration may bias genome-wide association studies on prostate cancer.
Dluzniewski PJ; Xu J; Ruczinski I; Isaacs WB; Platz EA
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):88-93. PubMed ID: 25352524
[TBL] [Abstract][Full Text] [Related]
36. The prostate cancer susceptibility variant rs2735839 near KLK3 gene is associated with aggressive prostate cancer and can stratify gleason score 7 patients.
He Y; Gu J; Strom S; Logothetis CJ; Kim J; Wu X
Clin Cancer Res; 2014 Oct; 20(19):5133-5139. PubMed ID: 25274378
[TBL] [Abstract][Full Text] [Related]
37. Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.
Wiklund F; Zheng SL; Sun J; Adami HO; Lilja H; Hsu FC; Stattin P; Adolfsson J; Cramer SD; Duggan D; Carpten JD; Chang BL; Isaacs WB; Grönberg H; Xu J
Prostate; 2009 Mar; 69(4):419-27. PubMed ID: 19116992
[TBL] [Abstract][Full Text] [Related]
38. Contribution of allelic variability in prostate specific antigen (PSA) & androgen receptor (AR) genes to serum PSA levels in men with prostate cancer.
Chavan SV; Maitra A; Roy N; Chavan PR
Indian J Med Res; 2014 Mar; 139(3):371-8. PubMed ID: 24820830
[TBL] [Abstract][Full Text] [Related]
39. Pathway analysis of genome-wide association study on serum prostate-specific antigen levels.
Ge YZ; Xu Z; Xu LW; Yu P; Zhao Y; Xin H; Wu R; Tan SJ; Song Q; Wu JP; Li WC; Zhu JG; Jia RP
Gene; 2014 Nov; 551(1):86-91. PubMed ID: 25168891
[TBL] [Abstract][Full Text] [Related]
40. Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
Kader AK; Sun J; Isaacs SD; Wiley KE; Yan G; Kim ST; Fedor H; DeMarzo AM; Epstein JI; Walsh PC; Partin AW; Trock B; Zheng SL; Xu J; Isaacs W
Prostate; 2009 Aug; 69(11):1195-205. PubMed ID: 19434657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]